TABLE 6.
Condition | Phase | Subjects | Dose | Outcomes | References |
Chronic kidney disease | III | 20 | 500 mg/day 4 week | RSV treatment had no antioxidant or anti-inflammatory effects | Saldanha et al., 2016 |
Inflammatory markers | NA | 44 | 400 mg RSV + 100 mg Quercetin/day 30 day | RSV treatment had beneficial effect on some inflammatory markers and reduced fasting insulin concentration | Agarwal et al., 2013 |
Inflammatory markers in smokers | III | 40 | 500 mg/day 30 day | RSV treatment had beneficial effects on some inflammatory markers and the antioxidant level | Bo et al., 2013 |
Polycystic ovary syndrome | NA | 40 | 1,500 mg/day 3 m | RSV treatment reduced ovarian and adrenal androgens | Banaszewska et al., 2016 |
Inflammatory markers | NA | 22 | 200 mg RSV + 100 mg Curcumin | RSV/Curcumin treatment had no effect on inflammation after consumption of a high-fat meal | Vors et al., 2018 |
Endometriosis | IIII | 44 | 40 mg/day 42 day | RSV treatment had no effect on endometriosis pain | Mendes da Silva et al., 2017 |
Osteoarthritis | III | 164 | Recruiting | NCT02905799 | |
Chronic kidney disease | NA | 25 | Recruiting | NCT03597568 |